…other regions. Benchling launches beta for biomolecule design R&D cloud platform provider Benchling has launched a new artificial intelligence (AI) programme to help scientists predict 3D structures of novel proteins….
…diseases and artificial intelligence network science-based algorithms. The platform identifies biologically similar patients and drug targets that are specific to those patients to improve response rates. Official comments “By partnering…
R&D cloud platform provider Benchling has launched a new artificial intelligence (AI) programme to help scientists predict 3D structures of novel proteins. The company has launched a beta version of…
Drug discovery and development is a challenging multiparameter optimisation problem. Harnessing the power of artificial intelligence (AI) can help accurately predict the behaviour and properties of small molecules. In this…
Artificial intelligence company Iktos has announced a collaboration with drug discovery company Sygnature Discovery in a deal designed to accelerate drug discovery and development. The three-year deal will see Sygnature…
…and artificial intelligence to deliver behavioural change health benefits and is being applied to chronic illnesses such as diabetes and ulcerative colitis. Sidekick is working with companies including Pfizer and…
…Indeed, this era of large drug development and manufacturing, referred to as “Bioprocess 4.0,” focuses on application of machine learning and artificial intelligence to enable predictive modeling, automation, and optimisation…
For the last seven years, the LSX World Congress has bought together biotech, medtech and healthtech executives to connect with the capital, intelligence, innovation, and partners they need to grow…
…features: Premium app-only content; the latest industry news brought to you as it happens; interviews; market reports; updates on the latest technology; trends and analysis; and articles and intelligence from…
…and intelligence from the DDW quarterly publication including archived issues. To download the DDW app for Apple devices click here. To download the DDW app for Android devices click here….
Artificial intelligence (AI) company BenevolentAI and not-for-profit R&D organisation Drugs for Neglected Disease initiative (DNDi) have launched a joint research project to tackle dengue, one of the world’s most prevalent…
Artificial intelligence (AI) company X-Chem has announced that its drug discovery platform XD3 is now available to biopharma partners and clients. XD3 is the company’s small molecule drug discovery platform…
…Shah: What’s going to happen over the next few years is technology is going to make a big impact. Artificial intelligence will be put into the CRO market to consolidate…
…The test works by applying whole-genome sequencing and artificial intelligence (AI) to a 3-4mL blood sample to support rapid and accurate detection of cancer, monitor disease progression, and evaluate therapeutic…
Noor Shaker, the Senior Vice President and General Manager for DNA technology company X-Chem, has been named a winner in the Artificial Intelligence Excellence Awards programme from Business Intelligence Group….
